REFERENCES
- Mazuel C. Norfloxacin. Analytical Profiles of Drug Substances, K. Florey. Academic, San Diego, CA 1991; 20: 557–600
- Sifton D. W. Physicians' Desk Reference (PDR). 49th ed., Medical Economics, New York 1995; 1600–1602
- Hor H. MIMS. Medi Media 1998; 27(1)204–210
- The Merck Index, S. Buduvari. 12th ed., Merck and Company, Rahway, NJ 1996; 1150
- Ansel H. C. Introduction to Pharmaceutical Dosage Forms. 4th ed., Lea and Febiger, Philadelphia, PA 1985; 207–222
- Nairn J. G. Solutions, Emulsions, Suspensions and Extracts. Remington: the Science and Practice of Pharmacy, A. R. Gennaro. 19th ed., Mack Publishing, Easton, PA 1995; 1515–1521
- U.S. Pharmacopeial Convention. The United States Pharmacopeia. 23rd rev., Author, Rockville, MD 1995; 1103–1104
- Parasrampuria J., Gupta V. D. Drug Dev. Ind. Pharm. 1990; 16(9)1597–1604